Point-of-Sale Finance Series: The Great Debate of Loans vs. Credit Sales — The Consumer Finance Podcast
Explore the Impact of Point-of-Sale Finance in Our Upcoming Series — The Consumer Finance Podcast
Podcast — UK FinReg Focus Areas in 2025: Retail Markets
5 Key Takeaways | State Sales Tax in 2024: What Every Retailer Needs to Know
Exploring the Potential of Georgia's Merchant Acquirer Limited Purpose Bank Charter — Payments Pros: The Payments Law Podcast
Podcast: The Briefing - Shedding Light on ‘Willful Blindness’: Brandy Melville v Redbubble
Podcast - Trends Affecting the Grocer and Retail Space
State AG Pulse | Wrangling Acronyms: SAGs, ORC and AI
Litigation Lessons for California Employers
Fashion Counsel: Pricing Strategies and Antitrust Considerations
Pricing Strategies and Antitrust Considerations
5 Key Takeaways | Emerging Technology in Retail and Consumer Goods
Supply Chain Disruptions with Special Guest Chris Mills, CEO of Lion Brand Yarn
2022 Bankruptcy & Restructuring Outlook
Is Your Brand "Sustainable"? How Retail Companies Can Stay in the Green
Nota Bene Episode 135: Europe Q3 Check In: Brexit, Data Protection, and Block Exemption Regulations with Oliver Heinisch
Podcast: Federal and State Cannabis Rules Are Moving in Different Directions - Diagnosing Health Care
The Intersection of Insurance and Bankruptcy – Part 1
Cannabis Counsel Cast: What Cannabis Companies Need to Know About California’s Prop. 65 (Even if They Aren’t in California)
Last week, we reported Celltrion’s U.S. launch of STEQEYMA® (ustekinumab-stba), a biosimilar of Janssen’s STELARA® (ustekinumab). According to Celltrion, STEQEYMA® is being sold at a wholesale acquisition cost (WAC) list...more
The current outbreak of COVID-19 (the coronoavirus) will be a test of the global supply chain’s strength in the face of unintended interruptions, and can be a lesson on building-in supply-chain contingency plans. As a result...more